Dolutegravir-based Regimen Ensures High Virological Success despite prior Exposure to Efavirenz-based First-Line ART in Cameroon: An Evidence of a Successful Transition Model

被引：0

作者：

Semengue, Ezechiel Ngoufack Jagni ^{[1
]}

Abba, Aissatou ^{[1
]}

Angong, Grace ^{[1
]}

Christelle, Ka'e Aude ^{[1
]}

Bouba, Yagai ^{[1
]}

Ceccherini, Francesca ^{[2
]}

Chenwi, Collins Ambe ^{[1
]}

Colizzi, Vittorio ^{[2
]}

Dambaya, Beatrice ^{[1
]}

Djupsa, Sandrine ^{[1
]}

Etame, Naomi-Karell ^{[3
]}

Fokam, Joseph ^{[1
]}

Kouanfack, Charles ^{[4
]}

Meledie, Alain Patrice ^{[5
,6
]}

Mossiang, Leonella ^{[7
]}

Ndjolo, Alexis ^{[1
]}

Durand, Alex ^{[1
]}

Perno, Carlo-Federico ^{[8
]}

Martin, Sosso Samuel

Santoro, Maria Mercedes ^{[2
]}

Takou, Desire ^{[1
]}

Teto, Georges ^{[1
]}

Tchouaket, Michel Carlos Tommo ^{[9
]}

机构：

[1] Chantal Biya Int Reference Ctr Res HIV AIDS preve, Yaounde, Cameroon

[2] Univ Roma Tor Vergata, Rome, Italy

[3] Univ Catholique Afrique Cent, Lille, France

[4] Univ Dschang, Fac Med & Sci Pharmaceut, Dschang, Cameroon

[5] Hop Gen Douala, Douala, Cameroon

[6] Univ Evangel Cameroun, Yaounde, Cameroon

[7] Hop Cent Yaounde, Yaounde, Cameroon

[8] Bambino Gesu Pediat Hosp, Rome, Italy

[9] CIRCB, Yaounde, Cameroon

来源：

SEXUALLY TRANSMITTED DISEASES | 2024年 / 51卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

P135

引用

页码：S169 / S170

页数：2

共 7 条

[1] Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model
Semengue, Ezechiel Ngoufack Jagni
Fokam, Joseph
Etame, Naomi-Karell
Molimbou, Evariste
Chenwi, Collins Ambe
Takou, Desire
Mossiang, Leonella
Meledie, Alain P.
Yagai, Bouba
Nka, Alex Durand
Dambaya, Beatrice
Teto, Georges
Ka'e, Aude Christelle
Beloumou, Grace Angong
Ndjeyep, Sandrine Claire Djupsa
Abba, Aissatou
Kengni, Aurelie Minelle Ngueko
Tchouaket, Michel Carlos Tommo
Bouba, Nounouce Pamen
Billong, Serge-Clotaire
Sosso, Samuel Martin
Colizzi, Vittorio
Perno, Carlo-Federico
Kouanfack, Charles
Bissek, Anne-Cecile Zoung-Kanyi
Eben-Moussi, Emmanuel
Santoro, Maria Mercedes
Ceccherini-Silberstein, Francesca
Ndjolo, Alexis
VIRUSES-BASEL, 2023, 15 (01):
[2] Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first-line antiretroviral therapy regimen in Zimbabwe
Kouamou, Vinie
Washaya, Tendai
Mapangisana, Tichaona
Ndhlovu, Chiratidzo Ellen
Manasa, Justen
AIDS, 2024, 38 (05) : 689 - 696
[3] High acceptability and viral suppression rate for first-Line patients on a dolutegravir-based regimen: An early adopter study in Nigeria
Abudiore, Opeyemi
Amamilo, Ikechukwu
Campbell, Jennifer
Eigege, Williams
Harwell, Joseph
Conroy, James
Jiboye, Justus
Lufadeju, Folu
Amole, Carolyn
Wiwa, Owens
Anweh, Damien
Agbaji, Oche Ochai
Akanmu, Alani Sulaimon
PLOS ONE, 2023, 18 (05):
[4] Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study
Sawry, Shobna
Ayalew, Kassahun
Maimela, Gloria
Briggs-Hagen, Melissa
van Wyk-Heath, Marelize
Mthethwa, Simangele
Shai, Sannie
Mngomezulu, Nkululeko N.
Tlhowe, Lawrence
Achere-Darko, Josephine
Bedford, Jason
Martin, Catherine E.
Fairlie, Lee
Imrie, John
HIV MEDICINE, 2024, 25 (07) : 826 - 839
[5] Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial)
Bousmah, Marwan-al-Qays
Protopopescu, Camelia
Mpoudi-Etame, Mireille
Bassega, Pierrette Omgba
Maradan, Gwenaelle
Olinga, Justin
Varloteaux, Marie
Tovar-Sanchez, Tamara
Delaporte, Eric
Kouanfack, Charles
Boyer, Sylvie
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2023, 94 (03) : 262 - 272
[6] Concerns and clarifications regarding the article 'Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first line ART regimen in Zimbabwe'
Karabay, Oguz
AIDS, 2024, 38 (08)
[7] HIV Drug Resistance Profile in Clients Experiencing Treatment Failure After the Transition to a Dolutegravir-Based First-Line Antiretroviral Treatment Regimen in Mozambique
Ismael, Nalia
Hussein, Cidia
Magul, Cacildo
Inguane, Humberto
Couto, Aleny
Nhangave, Amancio
Muteerwa, Ana
Bonou, Mahoudo
Ramos, Artur
Young, Peter Wesley
Chilundo, Sonia
Machekano, Rhoderick
Greenberg, Lauren
da Silva, Juliana
Bhatt, Nilesh
PATHOGENS, 2025, 14 (01):

← 1 →